Onesource Specialty Pharma Limited has informed the Exchange about Copy of Newspaper Publication of Notice of 18th Annual General Meeting
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Onesource Specialty Pharma Limited (formerly Stelis Biopharma) has submitted copies of newspaper advertisements published on August 30, 2025, in the Financial Express (English) and Lokmat (regional/Marathi) regarding the notice of its 18th Annual General Meeting. This is noted as the company's first AGM since listing on the stock exchanges. The filing is a continuation of an earlier intimation dated August 29, 2025, and is signed by Company Secretary Trisha A. The AGM notice also covers provisions for remote e-voting by shareholders. The company is listed on BSE (scrip code 544292) and NSE (symbol: ONESOURCE).
This is a routine regulatory compliance filing required by SEBI listing rules and does not signal any material business development. Shareholders should watch for the actual AGM date and the resolutions to be voted on, but there is no immediate impact on the stock price.